| 产品描述: | Anti-inflammatory agent 36 is an anti-inflammatory agent. Anti-inflammatory agent 36 inhibits LPS-induced macrophage activation |
| 靶点: |
Immunology/Inflammationrelated |
| 体外研究: |
Anti-inflammatory agent 36 (化合物 5a28) (2.5-20 μM) 抑制 LPS 诱导的活化 RAW 264.7 小鼠巨噬细胞中 TNF-α 和 IL-6 的释放,IC50 为 3.69 (TNF-α) 和 3.68 µM (IL-6)。 Anti-inflammatory agent 36 (10 μM,0.5 小时) 抑制 RAW 264.7 小鼠巨噬细胞中 LPS 诱导的 P-P38 和 P-ERK。 Anti-inflammatory agent 36 (10 μM, 0.5 h) 抑制 LPS 诱导的 TNF-α、IL-6、IL-1β、ICAM-1 和 VCAM-1 的转录。 |
| 体内研究: |
Anti-inflammatory agent 36 (化合物 5a28) (10 mg/kg,腹腔注射) 抑制急性肺损伤小鼠模型的炎症。 Animal Model: Acute lung injury mouse model Dosage: 10 mg/kg Administration: i.p. Result: Reduced wet/dry weight ratio of the mice lungs.Reduced biomarkers of lymphocytes and macrophages.Suppresses TNF-α, IL-6, IL-1β, 7 VACM-1 and ICAM-1 level. |
| 参考文献: |
1. Qian J, et al. Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI). Eur J Med Chem. 2019 Apr 1;167:414-425. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.205 ml |
11.026 ml |
22.052 ml |
| 5 mM |
0.441 ml |
2.205 ml |
4.41 ml |
| 10 mM |
0.221 ml |
1.103 ml |
2.205 ml |
| 50 mM |
0.044 ml |
0.221 ml |
0.441 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |